Furthermore, onvansertib effectively reduced tumor growth in the transgenic LKB1fl/flp53fl/fl mouse model of endometrioid EC, which was accompanied by a reduction in the protein expression of Ki-67 and Plk1 and an increase in the expression of Bcl-xL in tumor tissues. The gene discussed is PLK1; the disease is neoplasm.